Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Joint Pain Personalised Treatment Assessment: Modified Release OxyContin vs Paracetamol in Hip Osteoarthritis
2005-004527-19Phase 4Completed
- Sponsor
- MRC Health Services Research Collaboration
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone in hip osteoarthritis (2 arms), sponsored by MRC Health Services Research Collaboration. Primary endpoint: Patient preferred treatment at 12 weeks. Started Oct 2005; status: completed.
02
Drugs
oxycodone
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2005-004527-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004527-19.